Genprex, Inc. (GNPX)

Latest Insider Confidence Score

2026Q1

49.4
Bearish

Company insider confidence (by quarter)

2018Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Nance Christy M. 10% Owner 3,117,694 Apr 5, 2018
Roth Jack A 10% Owner 646,960 Feb 14, 2019
Pham Julien L COO 432,692 Jan 29, 2019
Vaczy Catherine M EVP GC Chief Strategy Officer 265,000 Apr 24, 2023
Kumar Hermant 200,000 Feb 22, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Feb 27, 2026 Berger Mark Stanley Chief Medical Officer Sell 46.3 -7,168 -24.84% $14.3K
Feb 27, 2026 Feb 27, 2026 Confer Ryan M. CEO Sell 46.3 -9,330 -20.43% $18.7K
Dec 22, 2025 Dec 23, 2025 Moreno Toscano Jose Antonio Director Neutral 90.0 +9,000 5732.48% -
Dec 22, 2025 Dec 23, 2025 Berger Mark Stanley Chief Medical Officer Neutral 90.0 +28,500 7916.67% -
Dec 22, 2025 Dec 23, 2025 Confer Ryan M. CEO Neutral 90.0 +45,000 6807.87% -
Dec 22, 2025 Dec 23, 2025 LONGNECKER BRENT M Director Neutral 90.0 +9,000 5142.86% -
Dec 22, 2025 Dec 23, 2025 Wilson William R Jr. Director Neutral 90.0 +9,000 5732.48% -
Jun 30, 2025 Jul 1, 2025 Berger Mark Stanley Chief Medical Officer Sell 47.5 -4,500 -20.03% $1K
Jun 30, 2025 Jul 1, 2025 Confer Ryan M. CEO Sell 47.5 -5,775 -14.91% $1.3K
Feb 18, 2025 Feb 19, 2025 Berger Mark Stanley Chief Medical Officer Sell 47.5 -585 -2.54% $239.9
Feb 18, 2025 Feb 19, 2025 Confer Ryan M. CEO Sell 47.5 -395 -1.01% $162
Dec 5, 2024 Dec 6, 2024 Moreno Toscano Jose Antonio Director Neutral 90.0 +4,750 153.47% -
Dec 5, 2024 Dec 6, 2024 Wilson William R Jr. Director Neutral 90.0 +4,750 153.47% -
Dec 5, 2024 Dec 6, 2024 LONGNECKER BRENT M Director Neutral 90.0 +4,750 119.65% -
Dec 5, 2024 Dec 6, 2024 Confer Ryan M. CEO Neutral 90.0 +29,375 300.88% -
Dec 5, 2024 Dec 6, 2024 Berger Mark Stanley Chief Medical Officer Neutral 90.0 +18,250 379.73% -
Feb 18, 2024 Feb 21, 2024 Berger Mark Stanley Chief Medical Officer Sell 47.5 -1,319 -21.53% $5.8K
Feb 18, 2024 Feb 21, 2024 Varner John Rodney CEO Sell 46.3 -2,642 -8.95% $11.6K
Feb 18, 2024 Feb 21, 2024 Confer Ryan M. CFO Sell 47.5 -1,126 -10.34% $5K
Jun 27, 2023 Jun 29, 2023 Moreno Toscano Jose Antonio Director Neutral 90.0 +123,795 100.00% -
Jun 27, 2023 Jun 29, 2023 LONGNECKER BRENT M Director Neutral 90.0 +123,795 353.70% -
Jun 27, 2023 Jun 29, 2023 Wilson William R Jr. Director Neutral 90.0 +123,795 100.00% -
Apr 21, 2023 Apr 24, 2023 Varner John Rodney CEO Buy 78.8 +19,000 1.64% $20K
Apr 21, 2023 Apr 24, 2023 VACZY CATHERINE M EVP GC Chief Strategy Officer Buy 86.3 +20,000 8.16% $21.5K
Feb 18, 2023 Feb 22, 2023 VACZY CATHERINE M EVP GC Chief Strategy Officer Neutral 90.0 +245,000 100.00% -
Feb 18, 2023 Feb 22, 2023 Berger Mark Stanley Chief Medical Officer Neutral 90.0 +245,000 100.00% -
Feb 18, 2023 Feb 22, 2023 Kumar Hermant Chief Mfgr & Tech Officer Neutral 90.0 +200,000 100.00% -
Feb 18, 2023 Feb 22, 2023 Confer Ryan M. CFO Neutral 90.0 +245,000 128.61% -
Feb 18, 2023 Feb 22, 2023 Varner John Rodney CEO Neutral 90.0 +625,000 116.49% -
Jul 28, 2022 Aug 1, 2022 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Jul 29, 2022 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Jun 23, 2022 Jun 27, 2022 Moreno Toscano Jose Antonio Director Neutral 52.5 - 0.00% -
Jun 23, 2022 Jun 27, 2022 LONGNECKER BRENT M Director Neutral 52.5 - 0.00% -
Jun 23, 2022 Jun 27, 2022 Wilson William R Jr. Director Neutral 52.5 - 0.00% -
Jun 23, 2022 Jun 27, 2022 Kumar Hermant Chief Mfgr & Tech Officer Neutral 52.5 - 0.00% -
Jun 14, 2021 Feb 14, 2022 Varner John Rodney CEO Neutral 27.5 -1,614,152 -74.71% -
Feb 4, 2022 Feb 8, 2022 VACZY CATHERINE M EVP GC Chief Strategy Officer Neutral 52.5 - 0.00% -
Feb 4, 2022 Feb 8, 2022 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Feb 4, 2022 Feb 8, 2022 Varner John Rodney CEO Neutral 52.5 - 0.00% -
Feb 4, 2022 Feb 8, 2022 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% -
Feb 4, 2022 Feb 8, 2022 Kumar Hermant Chief Mfgr & Tech Officer Neutral 52.5 - 0.00% -
Sep 27, 2021 Sep 28, 2021 Kumar Hermant Chief Mfgr & Tech Officer Neutral 52.5 - 0.00% -
Sep 27, 2021 Sep 28, 2021 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% -
Sep 28, 2021 Kumar Hermant Chief Mfgr & Tech Officer Neutral 52.5 - 0.00% -
Sep 28, 2021 Berger Mark Stanley Chief Medical Officer Neutral 52.5 - 0.00% -
Jun 24, 2021 Jun 25, 2021 Wilson William R Jr. Director Neutral 52.5 - 0.00% -
Jun 24, 2021 Jun 25, 2021 Moreno Toscano Jose Antonio Director Neutral 52.5 - 0.00% -
Jun 24, 2021 Jun 25, 2021 LONGNECKER BRENT M Director Neutral 52.5 - 0.00% -
Apr 5, 2021 Apr 7, 2021 LONGNECKER BRENT M Director Buy 95.0 +15,000 75.00% $62.3K
Apr 7, 2021 LONGNECKER BRENT M Director Neutral 52.5 - 0.00% -
Mar 19, 2021 Mar 23, 2021 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Mar 19, 2021 Mar 23, 2021 VACZY CATHERINE M EVP GC Chief Strategy Officer Neutral 52.5 - 0.00% -
Mar 19, 2021 Mar 23, 2021 Varner John Rodney CEO Neutral 52.5 - 0.00% -
Mar 19, 2021 Mar 23, 2021 Redman Michael Thomas COO Neutral 52.5 - 0.00% -
Aug 21, 2020 Aug 25, 2020 Varner John Rodney CEO Neutral 52.5 - 0.00% -
Aug 21, 2020 Aug 25, 2020 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Jul 24, 2020 Jul 28, 2020 Moreno Toscano Jose Antonio Director Neutral 52.5 - 0.00% -
Jul 24, 2020 Jul 28, 2020 LONGNECKER BRENT M Director Neutral 52.5 - 0.00% -
Jul 24, 2020 Jul 28, 2020 Wilson William R Jr. Director Neutral 52.5 - 0.00% -
Mar 31, 2020 LONGNECKER BRENT M Director Neutral 52.5 - 0.00% -
Mar 31, 2020 Wilson William R Jr. Director Neutral 52.5 - 0.00% -
Mar 31, 2020 Wilson William R Jr. Director Neutral 52.5 - 0.00% -
Dec 30, 2019 Mar 20, 2020 Friedman David E. Director Neutral 52.5 - 0.00% -
Dec 30, 2019 Mar 20, 2020 Pearson Robert W. Director Neutral 52.5 - 0.00% -
Mar 20, 2020 Moreno Toscano Jose Antonio Director Neutral 52.5 - 0.00% -
Mar 20, 2020 Wilson William R Jr. Director Neutral 52.5 - 0.00% -
Mar 16, 2020 VACZY CATHERINE M EVP & Chief Strategy Officer Neutral 52.5 - 0.00% -
Mar 16, 2020 Redman Michael Thomas COO Neutral 52.5 - 0.00% -
Dec 30, 2019 Jan 2, 2020 Friedman David E. Director Neutral 52.5 - 0.00% -
Dec 30, 2019 Jan 2, 2020 Pearson Robert W. Director Neutral 52.5 - 0.00% -
Sep 5, 2019 Sep 9, 2019 Varner John Rodney CEO Buy 55.0 +1,800 0.08% $1.6K
Feb 21, 2019 BONFIGLIO JOHN N Director Neutral 52.5 - 0.00% -
Dec 5, 2018 Feb 14, 2019 ROTH JACK A 10% Owner Neutral 27.5 -250,000 -14.60% -
Nov 2, 2018 Feb 5, 2019 Friedman David E. Director Neutral 52.5 - 0.00% -
Nov 2, 2018 Feb 5, 2019 Varner John Rodney CEO Neutral 52.5 - 0.00% -
Nov 2, 2018 Feb 5, 2019 Pearson Robert W. Director Neutral 52.5 - 0.00% -
Jan 25, 2019 Jan 29, 2019 Varner John Rodney CEO Neutral 52.5 - 0.00% -
Jan 25, 2019 Jan 29, 2019 Pham Julien L COO Neutral 52.5 - 0.00% -
Jan 25, 2019 Jan 29, 2019 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Nov 2, 2018 Nov 6, 2018 Genprex, Inc. Director Neutral 52.5 - 0.00% -
Nov 2, 2018 Nov 6, 2018 Genprex, Inc. Director Neutral 52.5 - 0.00% -
Nov 2, 2018 Nov 6, 2018 Genprex, Inc. CEO Neutral 52.5 - 0.00% -
Sep 27, 2018 Oct 1, 2018 Ly Viet-An Hoan 10% Owner Neutral 27.5 -1,160,982 -96.99% -
Jul 30, 2018 Aug 2, 2018 Pham Julien L COO Buy 90.0 +500 100.00% $1.7K
Jul 27, 2018 Jul 31, 2018 Ly Viet-An Hoan 10% Owner Neutral 52.5 - 0.00% -
May 23, 2018 May 25, 2018 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
May 23, 2018 May 25, 2018 Pham Julien L COO Neutral 52.5 - 0.00% -
Mar 29, 2018 Apr 5, 2018 Varner John Rodney CEO Buy 65.0 +10,000 0.47% $50K
Mar 29, 2018 Apr 5, 2018 ROTH JACK A 10% Owner Buy 82.5 +40,000 1.70% $200K
Mar 29, 2018 Apr 5, 2018 Nance Christy M. 10% Owner Buy 85.0 +50,000 1.69% $250K
Mar 29, 2018 Varner John Rodney CEO Neutral 52.5 - 0.00% -
Mar 29, 2018 ROTH JACK A 10% Owner Neutral 52.5 - 0.00% -
Mar 29, 2018 Pham Julien L COO Neutral 52.5 - 0.00% -
Mar 29, 2018 Pearson Robert W. Director Neutral 52.5 - 0.00% -
Mar 29, 2018 Nance Christy M. 10% Owner Neutral 52.5 - 0.00% -
Mar 29, 2018 Ly Viet-An Hoan 10% Owner Neutral 52.5 - 0.00% -
Mar 29, 2018 Confer Ryan M. CFO Neutral 52.5 - 0.00% -
Mar 29, 2018 Friedman David E. Director Neutral 52.5 - 0.00% -